Skip to main content
PSTX logo

Poseida Therapeutics, Inc. (PSTX) Stock Analysis

DELISTED 2025

What happened to Poseida Therapeutics, Inc. (PSTX) stock?

Poseida Therapeutics, Inc. (PSTX) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
January 2025
Last recorded price (historical):
$9.50 (last quote on record before the January 2025 delisting; historical, not a current quote)
MCap: $926M| Vol: 21.34M| 52-wk range: $1.87 – $9.67

Market cap $926M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Poseida Therapeutics, Inc. (PSTX). Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies. Their pipeline targets unmet medical needs in areas like cancer and genetic disorders.

Last analyzed: May 10, 2026
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies. Their pipeline targets unmet medical needs in areas like cancer and genetic disorders.

Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.

Poseida Therapeutics, Inc. (PSTX) Healthcare & Pipeline Overview

Employees350
Model self-rating on this text: 71% (not a measure of the evidence) Updated: May 10, 2026

More about this archive record

Can I still buy PSTX shares?

No. PSTX stopped trading on public markets in January 2025, so the shares are not available through a broker. Anything you see quoted for PSTX elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before PSTX stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Poseida Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.